Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.

A new microfluidic device containing human cells that faithfully mimics the behavior of the blood-brain barrier is providing new insights into brain inflammation, the silent killer.

A team of Vanderbilt scientists have genetically modified luciferase, the enzyme that produces bioluminescence, so that it acts as an optical sensor that records activity in brain cells.

During development, neural circuits are remodeled – some synapses are eliminated and others are strengthened – to produce a mature, functional nervous system.

Provost and Vice Chancellor for Academic Affairs Susan R. Wente has appointed an 18-member committee of faculty and students to conduct the national search for the Barlow Family Director of the Vanderbilt Brain Institute chaired by Randolph Blake, Centennial Professor of Psychology, and Danny Winder, director for the Vanderbilt Center for Addiction Research.

“Neuro-diverse: A Symposium on Autism, Neuroscience and Perceptual Thinking” and an associated evening lecture – both free and open to the public – will take place on the Vanderbilt campus Monday, May 23.